Capmatinib dihydrochloride
CAS : 1197376-85-4
Ref. 3D-XXB37685
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Informations sur le produit
Capmatinib dihydrochloride is a molecule with antiproliferative, anti-angiogenic and cell death properties. It inhibits the c-met receptor tyrosine kinase, which is involved in tumor growth and angiogenesis. Capmatinib dihydrochloride has been shown to be effective against various cancers including breast cancer, non-small cell lung cancer, and prostate cancer. It also has an affinity for the antibody that targets the c-met receptor tyrosine kinase. This drug also has a patent and is one of the first in a new class of oncology drugs known as selpercatinibs. Capmatinib dihydrochloride can be used as a treatment for cancers that are resistant to other therapies or when other treatments have not worked.
Propriétés chimiques
Question d’ordre technique sur : 3D-XXB37685 Capmatinib dihydrochloride
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
